Zimmerman and colleagues examined how many depressed patients who scored in the remission range on the 17-item Hamilton Depression Rating Scale (HDRS) did not consider themselves to be in remission ...
Biohaven didn't receive the clinical readout it was hoping for over the festive period. | As the biopharma wound down for the ...
US clinical-stage biopharma Biohaven has reported disappointing results from a Phase II proof-of-concept study evaluating BHV ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback